These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9528183

  • 41. Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia.
    Ashihara K, Saito T, Mizumoto H, Nishimura M, Tanaka R, Kudo R.
    Med Electron Microsc; 2002 Mar; 35(1):9-15. PubMed ID: 12111402
    [Abstract] [Full Text] [Related]

  • 42. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ.
    In Vivo; 2003 Mar; 17(5):469-77. PubMed ID: 14598611
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G, Gnetti L, Merisio C, Melpignano M.
    Maturitas; 2007 Feb 20; 56(2):190-7. PubMed ID: 16963204
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Is progesterone insufficiency carcihogenic?].
    Mauvais-Jarvis P, Kuttenn F.
    Nouv Presse Med; 1975 Feb 01; 4(5):323-6. PubMed ID: 165465
    [Abstract] [Full Text] [Related]

  • 50. Endometrial cancer chemoprevention: implications of diverse pathways of carcinogenesis.
    Sherman ME, Sturgeon S, Brinton L, Kurman RJ.
    J Cell Biochem Suppl; 1995 Feb 01; 23():160-4. PubMed ID: 8747391
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Regression of latent endometrial precancers by progestin infiltrated intrauterine device.
    Ørbo A, Rise CE, Mutter GL.
    Cancer Res; 2006 Jun 01; 66(11):5613-7. PubMed ID: 16740697
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Hormonal interactions in endometrial cancer.
    Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W.
    Endocr Relat Cancer; 2000 Dec 01; 7(4):227-42. PubMed ID: 11174845
    [Abstract] [Full Text] [Related]

  • 57. Hypothesis for endometrial carcinoma carcinogenesis. Preventive prospects.
    Corocleanu M.
    Clin Exp Obstet Gynecol; 1993 Dec 01; 20(4):254-8. PubMed ID: 8281709
    [Abstract] [Full Text] [Related]

  • 58. Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones.
    Hale GE, Hughes CL, Cline JM.
    J Clin Endocrinol Metab; 2002 Jan 01; 87(1):3-15. PubMed ID: 11788613
    [No Abstract] [Full Text] [Related]

  • 59. [Systematic hormonal, chemotherapeutic, and surgical treatment of endometrial cancer and endometrial precancerous lesions].
    Trompeo P, Allara L.
    Minerva Ginecol; 1978 May 01; 30(5):354-6. PubMed ID: 673231
    [No Abstract] [Full Text] [Related]

  • 60. Endometrial carcinoma and its precursors.
    Sorosky JI, Olt GJ, Mortel R.
    Curr Ther Endocrinol Metab; 1994 May 01; 5():562-6. PubMed ID: 7704793
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.